Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1996
03/19/1996US5500425 Chroman derivatives and a method of treating 5-HT mediated disorders
03/19/1996US5500423 Analgesics
03/19/1996US5500421 Liver disorders
03/19/1996US5500420 Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
03/19/1996US5500418 Antiepileptic
03/19/1996US5500417 Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents
03/19/1996US5500415 Process for the preparation of spherules of active principles and emulsions containing the spherules
03/19/1996US5500340 Inhibition of IL-2 production by Tripterygium wilfordii Hook F extract
03/19/1996US5500230 Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
03/19/1996US5500227 Immediate release tablet cores of insoluble drugs having sustained-release coating
03/19/1996US5500226 Pharmaceutical composition having analgesic activity
03/19/1996US5500225 Monitoring melatonin levels and administering to compensate for deficiencies
03/19/1996US5500224 Pharmaceutical compositions containing nanocapsules
03/19/1996US5500222 Mixed with monoglyceride permeation enhancer
03/19/1996US5500215 Immunology
03/19/1996US5500212 Bile acid sequesterant, anticholesterol
03/19/1996US5500190 Anion exchange resin compositions containing almond paste for taste improvement
03/19/1996CA2109800C N-hydroxyurea derivatives which inhibit lipoxygenase
03/19/1996CA2014208C Selective blocking of spontaneously-active dopamine neurones in ventral tegmental area
03/19/1996CA1338168C Antibiotic ll-e19020 alpha and beta
03/17/1996CA2158223A1 Method for the preparation of 3-hydroxy-5-¬2-(dimethylamino)- ethyl|-2,3-dihydro-4-(methoxy -phenyl)-1,5-benzothiazepin-4 5h)-one and use of the product for making pharmaceutically active compounds
03/17/1996CA2158222A1 Use of substituted cyclopentane- di- and triones
03/16/1996WO1995007074A1 Composition for remedying drug dependence
03/16/1996CA2171083A1 Therapeutic composition for drug dependence
03/16/1996CA2158227A1 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives
03/16/1996CA2158225A1 Imidazopyridines
03/15/1996CA2157754A1 Percutaneous absorption preparation
03/14/1996WO1996007741A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
03/14/1996WO1996007737A1 A novel haemopoietin receptor
03/14/1996WO1996007668A1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes
03/14/1996WO1996007667A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids
03/14/1996WO1996007665A1 Anthracycline derivatives
03/14/1996WO1996007658A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE
03/14/1996WO1996007657A1 Pyrimido[5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them
03/14/1996WO1996007653A1 Endothelin receptor antagonists
03/14/1996WO1996007651A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/14/1996WO1996007649A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996WO1996007646A1 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
03/14/1996WO1996007641A1 Heterocyclic derivative and medicine
03/14/1996WO1996007637A1 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
03/14/1996WO1996007435A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
03/14/1996WO1996007430A1 Therapeutic treatment of clostridium difficile associated diseases
03/14/1996WO1996007427A1 Capsular polysaccharide immunomodulator
03/14/1996WO1996007423A1 Immunomodulating medicinal agent
03/14/1996WO1996007422A1 Use of il-4 for potentiation of chemotherapeutic agents
03/14/1996WO1996007420A1 Macrophage stimulating composition comprising a non-ionic surfactant
03/14/1996WO1996007419A1 2-halo-2'-deoxyadenosine treatment for histiocytosis
03/14/1996WO1996007418A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996WO1996007417A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996WO1996007416A1 Estrogens and parathyroid hormone for treating osteoporosis
03/14/1996WO1996007415A1 Myocardial protection using benzothiazepinones
03/14/1996WO1996007413A1 Compounds and methods for the treatment of cancer
03/14/1996WO1996007412A1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
03/14/1996WO1996007410A2 Depolarizing skeletal muscle relaxants
03/14/1996WO1996007409A1 Alkaloids and their antiviral agents
03/14/1996WO1996007408A1 Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt
03/14/1996WO1996007407A1 Methods of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine
03/14/1996WO1996007406A1 Combination of levobunolol and dipivefrin for ophthalmic use
03/14/1996WO1996007405A1 Excitatory amino acid receptor antagonists
03/14/1996WO1996007404A1 Use of selegiline to prolong life span
03/14/1996WO1996007403A1 Depressant of functions developed by molecule
03/14/1996WO1996007402A1 Triphenylethylenes for the prevention and treatment of osteoporosis
03/14/1996WO1996007400A1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
03/14/1996WO1996007397A2 Delivery of solid drug compositions
03/14/1996WO1996007392A2 Oligonucleotide prodrugs
03/14/1996WO1996007322A1 Method of sensitizing tumor cells with adenovirus e1a
03/14/1996WO1996002556A3 Oligonucleotides with anti-mdr-1 gene activity
03/14/1996WO1996002229A3 Soap composition
03/14/1996WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION
03/14/1996DE4432563A1 Use of phenoxy-alkoxy cpds. and amphiphilic anions
03/14/1996DE4432429A1 Pharmaceutical concentrates contg. lactic acid
03/14/1996DE4431867A1 New 4-amino-pyrimido-pyrimidine derivs.
03/14/1996DE4431832A1 Delayed release form of captopril in pellets in capsules
03/14/1996DE4430127A1 Kombinationspräparat, enthaltend Cyclosporin A oder FK506 und ein Xanthinderivat Combination preparation containing cyclosporin A or FK506 and a xanthine derivative
03/14/1996CA2199518A1 Heterocyclic derivative and medicine
03/14/1996CA2199508A1 Excitatory amino acid receptor antagonists
03/14/1996CA2199502A1 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
03/14/1996CA2199464A1 Oligonucleotide prodrugs
03/14/1996CA2199271A1 2-halo-2'-deoxyadenosine treatment for histiocytosis
03/14/1996CA2199265A1 Method of sensitizing tumor cells with adenovirus e1a
03/14/1996CA2199262A1 Use of il-4 for potentiation of chemotherapeutic agents
03/14/1996CA2199253A1 Novel crystal of cephalosporin compound
03/14/1996CA2199252A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996CA2199251A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996CA2199250A1 Estrogens and parathyroid hormone for treating osteoporosis
03/14/1996CA2198862A1 Myocardial protection using benzothiazepinones
03/14/1996CA2198621A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
03/14/1996CA2198477A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996CA2197873A1 A novel haemopoietin receptor
03/14/1996CA2197788A1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes
03/14/1996CA2197785A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids
03/14/1996CA2197714A1 Therapeutic treatment of clostridium difficile associated diseases
03/14/1996CA2197463A1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
03/14/1996CA2157950A1 Bicyclic oxazole and thiazole substituted ethers
03/13/1996EP0700914A1 Camptothecin derivatives, preparations thereof and antitumor agents
03/13/1996EP0700913A1 5,6-dihydro-4H-imidazo(4,5,1-ij)quinolines, processes for their preparation, their use as medicaments, and intermediate compounds
03/13/1996EP0700911A1 Imidazole derivatives having anti-HIV activity
03/13/1996EP0700906A1 Heterocyclic derivatives of N-phenylamides
03/13/1996EP0700905A1 Tricyclic pyrazole derivatives
03/13/1996EP0700904A1 Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicaments containing them as well as intermediates for their preparation
1 ... 6934 6935 6936 6937 6938 6939 6940 6941 6942 6943 6944 6945 6946 6947 6948 6949 6950 6951 6952 6953 6954 ... 7860